Apurva Yeluru, MD
Hospitalist · Dallas, TXNPI 1073969408
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Bayer accounts for 74.0% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $3,546, more than ten times the $94 reported in 2019. Among hospitalist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $72.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$3K
- Gilead$152
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$138
- Pfizer$135
- Johnson & Johnson$113
- Ferring Pharmaceuticals Inc.$89
- plus $547 from 11 others
What the payments were for
- Consulting fees$2,61058%
- Travel & lodging$571%
- Food & beverage$1,85441%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 6 | $3,346 |
| Gilead | 7 | $152 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $138 |
| Pfizer | 6 | $135 |
| Johnson & Johnson | 5 | $113 |
| Ferring Pharmaceuticals Inc. | 3 | $89 |
| Shionogi Inc | 4 | $84 |
| Merck | 4 | $75 |
| Vifor Pharma, Inc. | 3 | $65 |
| Boehringer Ingelheim | 4 | $63 |
| CSL Behring | 3 | $55 |
| AstraZeneca(2 entities) | 3 | $55 |
| Aimmune Therapeutics, Inc. | 2 | $53 |
| Novartis | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| Vertex | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$3,226
How this compares
$4,521 in reported general payments places this provider in the 95th percentile of 1,284 hospitalist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carvedilol | 12 | $28 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Dallas
- Weiyi TanDallas$30K
- Ali BagheriDallas$11K
- Radha YalamanchiliDallas$6K
- Toby MathewDallas$5K
- Jaini SutariaDallas$4K
- Theo SotteroDallas$4K
- Neeraj KalraDallas$3K
- Mahmoud ElsayedDallas$2K
- Kenechukwu EnekebeCorpus Christi$311K
- Ryan NealHouston$154K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.